The RICTOR amplification in squamous cell lung carcinoma was linked with a bad prognosis and short survival.87 Further, this study showed the sensitivity of mTORC1/2 inhibitors against RICTOR-amplified lung cancer cells. Here, RICTOR is linked to lung carcinoma.